相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model
Iori Sakai et al.
CANCER SCIENCE (2011)
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
J-F Rossi et al.
BRITISH JOURNAL OF CANCER (2010)
Pharmacokinetic and Pharmacodynamic Modeling of an Anti-Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
Thomas Puchalski et al.
CLINICAL CANCER RESEARCH (2010)
Siltuximab, a Novel Anti-Interleukin-6 Monoclonal Antibody, for Castleman's Disease
Frits van Rhee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Assessment of the Impact of Renal Impairment on Systemic Exposure of New Molecular Entities: Evaluation of Recent New Drug Applications
Y. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Contribution of Down-Regulation of Intestinal and Hepatic Cytochrome P450 3A to Increased Absorption of Cyclosporine A in a Rat Nephrosis Model
Tomoe Fujita et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480
DJ George et al.
CLINICAL CANCER RESEARCH (2005)
Comparative pharmacokinetics of weekly and every-three-weeks docetaxel
SD Baker et al.
CLINICAL CANCER RESEARCH (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma
LZ Wang et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2003)
Interleukin-6 and prostate cancer progression
PC Smith et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
分享论文
